Health and Human Services Secretary Robert F. Kennedy, Jr. said Wednesday that he has ordered a top-down review of the abortion drug mifepristone in light of “alarming” research showing the Food and Drug Administration (FDA)-approved pill does far more harm to women than previously reported.
The
latest research is “alarming,” Kennedy said during a hearing before the
Senate Health, Education, Labor and Pensions Committee. “And clearly it
indicates at the very least the [FDA] label should be changed.” ---More...
A new study on the chemical abortion drug shows 11% of women experience adverse effects serious enough to send them to the ER@SecKennedy just pledged to conduct a top-to-bottom review of the drug - and said the FDA label needs to change
— Josh Hawley (@HawleyMO)May 14, 2025
That's a win for life pic.twitter.com/gy65iCZjI5